ConductScience.org, home

Paper4138633

Strong stimulation of CBA lymphocytes in the mixed lymphocyte interaction with cells from the H-2-indentical strain C3H.

Lilliehöök B and 1 other. Scand J Immunol, 1974. Cited by 63 papers, by iCite.

Cite this record

ConductScience Library. Strong stimulation of CBA lymphocytes in the mixed lymphocyte interaction with cells from the H-2-indentical strain C3H. Papers, record 4138633. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4138633

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Strong stimulation of CBA lymphocytes in the mixed lymphocyte interaction with cells from the H-2-indentical strain C3H.
PubMed
Journal
Scand J Immunol
PubMed
Year
1974
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
63
iCite
Relative citation ratio, by iCite
2.5
iCite
Revised in PubMed
2019-08-18
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lilliehöök BB
2Blomgren HH

Source PubMed

Download CSV of authors

Topics22

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Histocompatibility AntigensMajor topic
LymphocytesMajor topic
Age Factors
Animals
Antigen-Antibody Reactions
Cells, Cultured
Epitopes
Female
Histocompatibility
Histocompatibility Testing
Lymph Nodes
Lymphocyte Culture Test, Mixed
Male
Methods
Mice
Mice, Inbred C3H
Mice, Inbred C57BL
Mice, Inbred CBA
Mitomycins
Spleen
T-Lymphocytes
Thymectomy

Source PubMed

Download CSV of topics

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 63 citations.

PMIDTitleJournalYearIn PapersSource
16250785Anticipatory immune changes in women treated with chemotherapy for ovarian cancer.Int J Behav Med1995https://conductscience.org/library/papers/16250785PubMed
6839546In vitro and in vivo effects of interferon on the response of human lymphocytes to mitogens.Clin Exp Immunol1983https://conductscience.org/library/papers/6839546PubMed
6261248Alteration of lymphocyte surface properties by insertion of foreign functional components of plasma membrane.Proc Natl Acad Sci U S A1980https://conductscience.org/library/papers/6261248PubMed
3632915Relation between the site of primary intracranial tumors and mitogenic responses of blood lymphocytes.Cancer Immunol Immunother1986https://conductscience.org/library/papers/3632915PubMed
3196888Influence of adjuvant tamoxifen on blood lymphocytes.Breast Cancer Res Treat1988https://conductscience.org/library/papers/3196888PubMed
2954635Influence of alpha-interferon therapy on blood lymphoid cells. Studies on antibody production, mixed lymphocyte culture response, mitogen responsiveness and 2'-5'oligoadenylate synthetase activity.Cancer Immunol Immunother1987https://conductscience.org/library/papers/2954635PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/4138633

GET https://conductscience.org/api/papers/v1/4138633/authors